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1684-1182/Copyright ª 2015, TaiwanBackground/Purpose: Helicobacter pylori-induced gastric mucosal inflammation is mediated
by proinflammatory and anti-inflammatory cytokines. Polymorphisms in genes that code cyto-
kines influence cytokine secretion levels and appear to contribute to the risk of gastric dis-
eases. In this sense, we performed this study to identify the polymorphisms in the IL-6, IL-8,
and IL-10 genes and their associations with H. pylori infection and gastric pathologies.
Methods: Gastric biopsy samples of 151 patients infected with H. pylori and 76 uninfected in-
dividuals were used. Helicobacter pylori infection was diagnosed by histological examination
and the detection of the ureA and glmM genes. The polymorphisms in the IL-6 (at position
174), IL-8 (at position 251), and IL-10 (at position 819) were detected by polymerase chain
reactionerestriction fragment length polymorphism.
Results: Among the genetic polymorphisms studied, we observed that only the presence of the
A allele at position 251 of the IL-8 gene was significantly associated with H. pylori infection.
In addition, patient carriers of the A/A genotype at position 251 of the IL-8 gene and carriers
of the T allele at position 819 of the IL-10 gene had an increased risk of peptic ulcer disease
in the presence of H. pylori infection. We did not find a correlation between polymorphisms in
the IL-6, IL-8, and IL-10 genes and a higher risk of gastric carcinoma.Federal de Pelotas (UFPel), Campus Universita´rio S/NeCapa˜o do Lea˜o, 96010-900 Pelotas, RS, Brazil.
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j.jmii.2015.03.002Conclusion: We demonstrated that polymorphisms in the IL-8 gene was significantly associated
with H. pylori infection. Furthermore, polymorphisms in the IL-8 and IL-10 genes were associ-
ated with an enhanced risk of peptic ulcer disease in H. pylori-positive patients.
Copyright ª 2015, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Helicobacter pylori is a bacterium that causes various dis-
eases such as chronic gastritis, peptic ulcer disease, gastric
carcinoma, and mucosa-associated lymphoid tissue lym-
phoma.1 The key pathophysiological event in H. pylori
infection is the induction of an inflammatory response in
the gastric mucosa, which is mediated and regulated by
inflammatory cytokines produced by epithelial cells.2,3
Polymorphisms in genes encoding cytokines such as inter-
leukin (IL)-6, IL-8, and IL-10 influence the cytokines’
secretion levels and appear to contribute to the risk of
developing gastroduodenal diseases.4e6
Interleukin-6 is a proinflammatory cytokine that func-
tions as an inflammatory mediator and an endocrine regu-
lator. In addition, it has an important role in host defense
mechanisms as a messenger between innate and adaptive
systems.7 The IL-6 gene is located on chromosome 7. A
polymorphism in the 50 flanking region at position 174
(G/C) has been described3. This polymorphism may result
in interindividual variations in the transcription and
expression of the IL-6 gene, and therefore influence an
individual’s susceptibility to a diverse range of diseases,
which include H. pylori infection, and underlying patho-
genesis. The gastric mucosal levels of IL-6 are elevated in
H. pylori-associated gastritis and diminished after the
eradication of the infection.3,8 In addition, gastric levels of
IL-6 are reportedly increased in H. pylori-positive in-
dividuals with gastric carcinoma.9
Interleukin-8 is another proinflammatory cytokine that
has an important role in the pathogenesis of H. pylori-
induced diseases.10 The high expression of IL-8 has been
demonstrated41 in gastric mucosa infected with H. pylori.
IL-8 causes chemotaxis and the activation of inflammatory
cells in gastric mucosa infected with H. pylori.11 The IL-8
gene, which is located on chromosome 4, exhibits a single
nucleotide polymorphism (SNP TeA base transition) at
251 nt relative to the transcription start site.12,13 The A
allele tends to be associated with increased IL-8 production
and consequently with an amplified inflammatory
response.3,12
Unlike the two aforementioned cytokines, IL-10 is an
anti-inflammatory cytokine that downregulates cell-
mediated immune responses and cytotoxic inflammatory
responses.14 Helicobacter pylori can lead to IL-10 upregu-
lation as a way to suppress an efficient immune response,
which then favors infection and parasite survival.15 The
gene encoding human IL-10 is located on chromosome 1.
Two SNPs that are associated with low IL-10 production
have been reported in the promoter region of this gene: a
CeT base transition at position 819 and a CeA baseamis IB, et al., Polymorphisms of
pylori, Journal of Microbiologytransition at position 592.16,17 The low IL-10 production is
associated with increased gastric inflammation intensity
and with an enhanced risk of gastric carcinoma in patients
infected with H. pylori.18,19
In this context, the identification of host genetic poly-
morphisms associated with the protection from or the in-
duction of gastric disease in individuals of different
ethnicities can allow a better prognosis of H. pylori infec-
tion. In the present study, we aimed to determine the
frequency of polymorphisms in the IL-6, IL-8, and IL-10
genes in patients from the south region of Brazil, to analyze
the association of these polymorphisms with H. pylori
infection, and to investigate the relation between these
polymorphisms and normal gastric mucosa, gastritis, peptic
ulcer disease, and gastric carcinoma.Methods
Patients and gastric biopsy samples
The present study included 227 patients (125 women and
102 men with an average age of 53.4 years): 151 H. pylori-
positive patients (23 patients with a normal gastric mu-
cosa, 86 patients with gastritis, 37 patients with peptic
ulcer, and 5 patients with gastric cancer) and 76 H. pylori-
negative patients (15 patients with a normal gastric mu-
cosa, 45 patients with gastritis, 12 patients with peptic
ulcer, and 4 patients with gastric cancer). The average age
of the H. pylori-positive patients was 52.4 years and the
average age of the H. pylori-negative patients was 54.4
years. Eight biopsy samples were obtained from each pa-
tient. Of these, four samples were destined for histology
(two samples from the gastric antrum and two samples
from the gastric body), whereas the remaining four sam-
ples were intended for polymerase chain reaction (PCR)
(two samples from the gastric antrum and two samples
from the gastric body). Helicobacter pylori infection was
diagnosed by histology and by the detection of the ureA
and glmM genes by PCR, as described later. Patients were
considered as infected with the bacterium when positive
results were obtained in at least two of the three tested
methods and considered as uninfected when the results of
all diagnostic tests were negative. The diagnosis of
gastroduodenal diseases was based on endoscopic and
histological examinations and established in accordance
with the Sydney System Classification. This work was
approved by the Research Ethics Committee of the Health
Area [Universidade Federal do Rio Grande (FURG); process
number 23116.001044/2011-16]. Written, informed con-
sent was obtained from all patients.the IL-6, IL-8 and IL-10 genes and the risk of gastric pathology in
, Immunology and Infection (2015), http://dx.doi.org/10.1016/
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Gastric biopsy samples that were destined for histology were
fixed in 10% formalin after collection, and were stained with
hematoxylin-eosin (H&E) and Giemsa. Microscopic examina-
tion defined the degree of involvement of the gastric mucosa
and the presence of H. pylori. After collection, the samples
that were intended for PCR were kept in brain heart infusion
broth with 20% glycerol. They were then stored at 70C for
further extraction. The DNA was extracted using DNAzol
Reagent (Invitrogen Life Technologies, Carlsbad, USA) and
proteinase K (Ludwig Biotec, Porto Alegre, Brazil) and 10 mg/
mL of proteinase K, as described previously by Fonseca
et al.20 The integrity of the extracted DNA was assessed by
the amplification of a 110-base pair (bp) fragment, which is
specific to human b-globin, using initiator oligonucleotides
and a methodology already reported in another study.21
Helicobacter pylori infection was diagnosed by PCR using
two sets of primers: UREA1eUREA2, which amplifies a 394-
bp fragment that corresponds to the ureA gene,22 and
GLM/MFeGLM/MR, which amplifies a 140-bp fragment that
corresponds to the glmM gene.23Genotyping of cytokine polymorphisms
Polymorphisms in the IL-6, IL-8, and IL-10 genes were
detected by PCR-restriction fragment length polymorphism
(RFLP). To investigate the polymorphism at position 174
of the IL-6 gene, we used the primers 50-TTGTCAAGA-
CATGCCAAAGTG-30 (forward) and 50-TCAGACATCTCCA
GTCCTATA-30 (reverse).24 The PCR was performed under the
conditions described by Gatti et al.24 The PCR products
were digested with the restriction enzyme NlaIII, and then
analyzed by electrophoresis on 3.5% agarose gel stained
with ethidium bromide. The genotypes were designated as
follows: G/G, three bands consisting of 233 bp, 54 bp, and
13 bp; G/C, five bands consisting of 233 bp, 122 bp, 111 bp,
54 bp, and 13 bp; and C/C, four bands consisting of 122 bp,
111 bp, 54 bp, and 13 bp.24
To analyze the polymorphism at position 251 of the IL-8
gene, the primers used were 50-TTCTAACACCTGCCACT
CTAG-30 (forward) and 50-CTGAAGCTCCACAATTTGGTG-30
(reverse).25 The PCR was performed as previously reported
in another study.25 The PCR products were digested with
the restriction enzyme MfeI, and then visualized by elec-
trophoresis on 3.5% agarose gel stained with ethidium
bromide. The genotypes were coded as follows: T/T, a
single band consisting of 108 bp; T/A, three bands con-
sisting of 108 bp, 76 bp, and 32 bp; and A/A, two bands
consisting of 76 bp and 32 bp.25
To determine the polymorphism at position819 of the IL-
10 gene, primers 50-ATCCAAGACAACACTACTAA-30 (forward)
and 50-TAAATATCCTCAAAGTTCC-30 (reverse) were used.26
The PCR was performed under the conditions described by
Cheng et al.26 The PCR products were digested with the re-
striction enzymeMaeIII, and then analyzed by electrophoresis
on 2.5% agarose gel stained with ethidium bromide. The ge-
notypes were designated as follows: C/C, three bands con-
sisting of 292 bp, 217 bp, and 79 bp; C/T, four bands consisting
of 509 bp, 292 bp, 217 bp, and 79 bp; and T/T, two bands
consisting of 509 bp and 79 bp.26 To ratify the results obtainedPlease cite this article in press as: Ramis IB, et al., Polymorphisms of
patients infected with Helicobacter pylori, Journal of Microbiology
j.jmii.2015.03.002by PCR-RFLP for the IL-6, IL-8, and IL-10 genes, 10% of samples
evaluated for each polymorphism were randomly selected
and confirmed by DNA sequencing.
Statistical analysis
The sample size was calculated using Epi-info 6.04 software
(Centers for Disease Control and Prevention, Atlanta, GA). A
95% confidence level was used. The estimated prevalence of
the IL-6 polymorphism was 8% with an error of 4%. We choose
this polymorphism for the calculation of the “n” because is
the less frequent among the studied. We found 193 patients
added of 15% of loss. The data was typed on a bank in the
Microsoft Excel 2010 program (Microsoft Corporation, Red-
mond,Washington, USA). The consistency analysis, whichwas
based on the creation and categorization of variables and
verification of frequencies, was performed using SPSS version
18.0 (Statistical Program for the Social Sciences Inc., Chicago,
USA). The Chi-square test or Fisher’s exact test were used to
compare between proportions. Values of p < 0.05 were
considered statistically significant. A prevalence ratio (PR)
with a 95% confidence interval (CI) was calculated to evaluate
the relationship between cytokine gene polymorphisms with
gastroduodenal diseases and with H. pylori infection.
Results
Table 1 shows the allelic and genotypic frequency referents
to polymorphisms in the IL-6, IL-8, and IL-10 genes in H.
pylori-positive and H. pylori-negative patients. Only the
presence of the A allele at position251 of the IL-8 gene was
significantly associated with H. pylori infection (pZ 0.039).
Table 2 displays the distribution of the allele and geno-
type referents to polymorphisms in the IL-6, IL-8, and IL-10
genes in H. pylori-positive and H. pylori-negative patients
with a normal gastric mucosa, gastritis, peptic ulcer dis-
ease, and gastric carcinoma. Helicobacter pylori-positive
patients and carriers of the A/A genotype at position 251
of the IL-8 gene had an increased risk of peptic ulcer dis-
ease (PR Z 2.08 and 95%CI Z 1.03e4.18). In addition,
patient carriers of the T allele at position 819 of the IL-10
gene in the presence of H. pylori infection had a higher risk
of peptic ulcer disease (PRZ 1.24 and 95%CIZ 1.01e1.53).
Discussion
Allelic variants in cytokine genes influence gene expression
and susceptibility to infectious diseases.27 Naito et al11
showed that the IL-8 levels in A allele carriers of the IL-8
T-251A polymorphism were slightly higher than in subjects
with the T/T genotype. In this study, unlike some previous
works, the presence of the A allele at position 251 of the
IL-8 gene was significantly associated with H. pylori infec-
tion (p Z 0.039), which suggests that this allele is associ-
ated with susceptibility to H. pylori infection and its
persistence.13,28 Xue et al13 showed in a meta-analysis that
the IL-8 -251AA genotype is not associated with the H. py-
lori infection status. However, Xue found that this geno-
type is associated with the overall risk of developing gastric
cancer. In 2013, Zhao et al28 investigated the correlationthe IL-6, IL-8 and IL-10 genes and the risk of gastric pathology in
, Immunology and Infection (2015), http://dx.doi.org/10.1016/







Alleles ➡ IL-6 (174) p Z 0.301a
G 218 (72.2) 114 (75.0) 1.0
C 84 (27.8) 38 (25.0) 1.05 (0.91e1.21)
Genotypes ➡ IL-6 (174) p Z 0.486b
G/G 79 (52.3) 45 (59.2) 1.0
G/C 60 (39.7) 24 (31.6) 1.12 (0.93e1.36)
C/C 12 (8.0) 7 (9.2) 0.99 (0.69e1.43)
Alleles ➡ IL-8 (251) p Z 0.039a
T 143 (47.4) 86 (56.6) 1.0
A 159 (52.6) 66 (43.4) 1.13 (0.99e1.29)
Genotypes ➡ IL-8 (251) p Z 0.139b
T/T 32 (21.2) 25 (32.9) 1.0
T/A 79 (52.3) 36 (47.4) 1.22 (0.94e1.59)
A/A 40 (26.5) 15 (19.7) 1.30 (0.98e1.72)
Alleles ➡ IL-10 (819) p Z 0.502a
C 208 (68.9) 104 (68.4) 1.0
T 94 (31.1) 48 (31.6) 0.99 (0.86e1.14)
Genotypes ➡ IL-10 (819) p Z 0.941b
C/C 72 (47.7) 35 (46.1) 1.0
C/T 64 (42.4) 34 (44.7) 0.97 (0.80e1.18)
T/T 15 (9.9) 7 (9.2) 1.01 (0.74e1.39)
a The p values were determined by Fisher’s exact test.
b The p values were determined by the Chi-square test.
95%CI, 95% confidence interval; H. pylori, Helicobacter pylori; IL-6/-8/-10, interleukin-6/-8/10; PR, prevalence ratio.
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ground of healthy populations in Indonesia. Zhao did not
observe a statistical significance between IL-8, IL-4, IL-1b,
CD14, TNF-a, and tyrosine-protein phosphatase non-
receptor type 11 (PTPN11) gene polymorphisms and H. py-
lori infection.
H. pylori-induced gastric mucosal inflammation is
mediated by an array of pro- and anti-inflammatory cyto-
kines.5 In general, studies show that this inflammation is
exacerbated in patients with a high production of alleles of
proinflammatory cytokines and a low production of alleles
of anti-inflammatory cytokines, which result in a higher risk
of peptic ulcer or gastric carcinoma.3 Ulcer occurs because
of a disequilibrium between defensive mucosa-protective
factors and aggressive injurious factors; carcinogenesis
occurs because of the accumulation of genetic alterations
and the dysfunction of cellular mechanisms that normally
maintain human genome integrity.29,30
In accordance with a previous report, H. pylori-positive
patients and carriers of the A/A genotype at position 251
of the IL-8 gene had an increased risk of peptic ulcer dis-
ease.31 Allele A is associated with higher IL-8 production,
and consequently with increased mucosal injury, by acti-
vating and recruiting neutrophils in response to infection by
H. pylori.32,33 However, unlike some papers that have re-
ported that polymorphisms in the IL-10 gene were not
associated with peptic ulcer, the current study concluded
the oposite.26,34,35
After analyzing gastric biopsy samples from 227 patients,
we found that patient carriers of the T allele at positionPlease cite this article in press as: Ramis IB, et al., Polymorphisms of
patients infected with Helicobacter pylori, Journal of Microbiology
j.jmii.2015.03.002819 of the IL-10 gene had a higher risk of peptic ulcer
disease in the presence of H. pylori infection. This allele is
associated with the decreased expression level of IL-10,
which stimulates the proinflammatory response.1 In 2010,
Cheng et al26 demonstrated among Taiwanese patients that
the IL-10 -819C/T genotype was associated with an
increased risk of gastritis, but not peptic ulcer disease.
Zambon et al34 previously showed among Italian patients
that the IL-10 -819T/T genotype was associated with in-
testinal metaplasia and with noncardia gastric cancer, but
not with peptic ulcer.
Despite the low sample size, we did not find a correla-
tion between polymorphisms in the IL-6, IL-8 and IL-10
genes and a higher risk of gastric carcinoma as Savage
et al,36 Alpı´zar-Alpı´zar et al,37 Savage et al.38 However,
other authors have reported a correlation.32,34,39 Ye et al32
observed that the IL-8 -251A allele seemed to increase the
risk of gastric adenocarcinoma through an enhanced in-
flammatory process in H. pylori-infected Koreans. Zambon
et al34 showed that the IL-10 -819T/T genotype among
Italian patients was associated with noncardia gastric can-
cer. These contradictory results may be related to genetic
and ethnic differences in populations and with differences
in the study designs, in the sample size used, in the pa-
tients’ age at diagnosis, and in the dietary habits. The
magnitude and direction of the inflammatory response is
directed by host genetic factors interacting with environ-
mental exposures.40
In 2009, Kang et al6 evaluated the same genetic poly-
morphisms that we studied and their associations withthe IL-6, IL-8 and IL-10 genes and the risk of gastric pathology in
, Immunology and Infection (2015), http://dx.doi.org/10.1016/
Table 2 The frequency of the polymorphisms of the IL-6, IL-8 and IL-10 genes in Helicobacter pylori-positive and Helicobacter pylori-negative patients with a normal gastric
mucosa and with different gastric disorders



































p Z 0.335b p Z 0.826b p Z 0.655b
G 34 (73.9) 25 (83.3) 1.0 122 (70.9) 65 (72.2) 1.0 52 (70.3) 18 (75.0) 1.0 10 (100.0) 6 (75.0) d
C 12 (26.1) 5 (16.7) 1.22 (0.84e1.79) 50 (29.1) 25 (27.8) 1.02 (0.84e1.24) 22 (29.7) 6 (25.0) 1.06 (0.83e1.34) d 2 (25.0) d
Genotypes
IL-6 (174)
p Z 0.328b p Z 0.908b p Z 0.643b
G/G 12 (52.2) 11 (73.3) 1.0 45 (52.3) 25 (55.6) 1.0 17 (46.0) 7 (58.3) 1.0 5 (100.0) 2 (50.0) d
G/C 10 (43.5) 3 (20.0) 1.47 (0.90e2.41) 32 (37.2) 15 (33.3) 1.06 (0.81e1.38) 18 (48.6) 4 (33.3) 1.16 (0.84e1.60) d 2 (50.0) d
C/C 1 (4.3) 1 (6.7) 0.96 (0.23e4.05) 9 (10.5) 5 (11.1) 1.0 (0.65e1.53) 2 (5.4) 1 (8.4) 0.94 (0.41e2.18) d d d
Alleles
IL-8 (251)
p Z 0.253b p Z 0.304b p Z 0.350b p Z 0.681a
T 23 (50.0) 19 (63.3) 1.0 86 (50.0) 51 (56.7) 1.0 29 (39.2) 12 (50.0) 1.0 5 (50.0) 4 (50.0) 1.0




p Z 0.458b p Z 0.465b p Z 0.482b p Z 0.757a
T/T 5 (21.7) 6 (40.0) 1.0 20 (23.3) 15 (33.3) 1.0 5 (13.5) 2 (16.7) 1.0 2 (40.0) 2 (50.0) 1.0
T/A 13 (56.6) 7 (46.7) 1.43 (0.69e2.95) 46 (53.4) 21 (46.7) 1.20 (0.86e1.67) 19 (51.4) 8 (66.6) 0.99 (0.58e1.67) 1 (20.0) d d
A/A 5 (21.7) 2 (13.3) 1.57 (0.71e3.49) 20 (23.3) 9 (20.0) 1.21 (0.83e1.76) 13 (35.1) 2 (16.7) 2.08 (1.03e4.18) 2 (40.0) 2 (50.0) 1.0 (0.25e4.0)
Alleles
IL-10 (819)
p Z 0.059b p Z 0.721b p Z 0.069b
C 30 (65.2) 13 (43.3) 1.0 124 (72.1) 63 (70.0) 1.0 47 (63.5) 20 (83.3) 1.0 7 (70.0) 8 (100.0) d
T 16 (34.8) 17 (56.7) 0.69 (0.46e1.04) 48 (27.9) 27 (30.0) 0.97 (0.79e1.18) 27 (36.5) 4 (16.7) 1.24 (1.01e1.53) 3 (30.0) d d
Genotypes
IL-10 (819)
p Z 0.132b p Z 0.730b p Z 0.241b
C/C 9 (39.1) 2 (13.3) 1.0 45 (52.3) 21 (46.7) 1.0 15 (40.5) 8 (66.7) 1.0 3 (60.0) 4 (100.0) d
C/T 12 (52.2) 9 (60.0) 0.70 (0.44e1.11) 34 (39.5) 21 (46.7) 0.91 (0.70e1.18) 17 (46.0) 4 (33.3) 1.24 (0.86e1.79) 1 (20.0) d d
T/T 2 (8.7) 4 (26.7) 0.41 (0.13e1.31) 7 (8.2) 3 (6.6) 1.03 (0.66e1.59) 5 (13.5) d d 1 (20.0) d d
a The p values were determined by Fisher’s exact test.
b The p values were determined by the Chi-square test.
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+ MODELgastroduodenal disease in a Korean population. They found
a significant positive association between the IL-8 -251A/A
genotype and the risk for H. pylori-associated gastric car-
cinoma and benign gastric ulcer. Furthermore, a synergistic
effect was observed between IL-10 -592A/A and IL-8 -251A/
A with respect to the development of gastric carcinoma and
benign gastric ulcer.
From this study, we suggest that polymorphisms in the
IL-8 and IL-10 genes are biologically important in the
pathogenesis of peptic ulcer disease in patients infected
with H. pylori. A limitation of this study was that the
limited number of patients who were evaluated were
diagnosed with peptic ulcer disease and principally with
gastric cancer. However, a multicenter evaluation of the
association between polymorphisms in the IL-6, IL-8, and IL-
10 genes and H. pylori infection and gastric pathologies in
individuals of different ethnicities could prove more reli-
ably the correlation between these polymorphisms and
gastroduodenal diseases. A better understanding of these
associations could determine the clinical significance of the
SNPs profile in the context of a H. pylori-related gastro-
duodenal disorder.Acknowledgments
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